Analysts Issue Forecasts for TSE:INO Q1 Earnings

Inovalis Real Estate Investment Trust (TSE:INO) – Analysts at Desjardins issued their Q1 2025 earnings per share estimates for shares of Inovalis Real Estate Investment Trust in a report issued on Wednesday, April 2nd. Desjardins analyst A. Leon expects that the company will post earnings of $0.01 per share for the quarter. Desjardins also issued estimates for Inovalis Real Estate Investment Trust’s Q1 2025 earnings at $0.01 EPS, Q2 2025 earnings at $0.02 EPS, Q3 2025 earnings at $0.03 EPS, Q4 2025 earnings at $0.02 EPS and Q4 2025 earnings at $0.02 EPS.

Inovalis Real Estate Investment Trust Stock Performance

About Inovalis Real Estate Investment Trust

Inovio Pharmaceuticals, Inc, a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids.